medroxyprogesterone acetate has been researched along with Sarcoma, Endometrial Stromal in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akashi, D; Kato, H; Minobe, S; Okamoto, K; Shimada, C; Todo, Y | 1 |
Iwazaki, M; Masuda, R; Nakamura, Y; Nakano, M; Sato, T; Shimada, A | 1 |
Aoki, Y; Ishikawa, M; Miyazaki, K; Nagai, Y; Nakayama, K; Yaegashi, N | 1 |
Mizuno, M; Nakanishi, T; Nawa, A; Yatabe, Y | 1 |
Iida, K; Ishibashi, M; Katagiri, A; Miyazaki, K; Nakayama, K; Nakayama, N; Shamima, Y | 1 |
5 other study(ies) available for medroxyprogesterone acetate and Sarcoma, Endometrial Stromal
Article | Year |
---|---|
Successful use of dydrogesterone as maintenance therapy in recurrent endometrial stromal sarcoma: a case report.
Topics: Antineoplastic Agents, Hormonal; Drug Administration Schedule; Dydrogesterone; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasms, Hormone-Dependent; Progestins; Quality of Life; Sarcoma, Endometrial Stromal; Treatment Outcome | 2013 |
Lobectomy of pulmonary metastasis of endometrial stromal sarcoma.
Topics: Adnexa Uteri; Chemoradiotherapy, Adjuvant; Dysostoses; Female; Humans; Hysterectomy; Lung Neoplasms; Lymph Node Excision; Medroxyprogesterone Acetate; Middle Aged; Pelvis; Pneumonectomy; Sarcoma, Endometrial Stromal; Thorax; Treatment Outcome; Uterine Neoplasms | 2013 |
Prolonged long-term survival of low-grade endometrial stromal sarcoma patients with lung metastasis following treatment with medroxyprogesterone acetate.
Topics: Adult; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Disease-Free Survival; Endometrial Neoplasms; Female; Humans; Hysterectomy; Lung Neoplasms; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Ovariectomy; Retrospective Studies; Sarcoma, Endometrial Stromal; Survival Analysis; Time Factors; Treatment Outcome | 2010 |
Long-term medroxyprogesterone acetate therapy for low-grade endometrial stromal sarcoma.
Topics: Adult; Antineoplastic Agents, Hormonal; Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Recurrence; Sarcoma, Endometrial Stromal; Survival Analysis; Uterine Neoplasms | 2012 |
[Two cases of endometrial stromal sarcoma (ESS) in which survival was prolonged by administration of MPA].
Topics: Antineoplastic Agents, Hormonal; Endometrial Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Sarcoma, Endometrial Stromal | 2008 |